Successful conversion surgery after FOLFIRINOX therapy in a patient with advanced pancreatic acinar cell carcinoma with a solitary peritoneal dissemination: A case report.
Sunao UemuraHiromichi MaedaNobuhisa TaniokaSachi YamaguchiMasaya MunekageHiroyuki KitagawaTsutomu NamikawaShota YamamotoTakuhiro KohsakiMitsuko IguchiKazushige UchidaKazuhiro HanazakiPublished in: Cancer reports (Hoboken, N.J.) (2022)
FOLFIRINOX may be effective in patients with pancreatic acinar cell carcinoma, and conversion surgery after FOLFIRINOX may be applicable to selective patients.
Keyphrases
- minimally invasive
- locally advanced
- coronary artery bypass
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- surgical site infection
- squamous cell carcinoma
- case report
- radiation therapy
- mesenchymal stem cells
- bone marrow
- acute coronary syndrome
- patient reported outcomes
- cell therapy